吉尼胺通过调节PI3K-Akt信号介导的亡来抑制口腔状细胞癌:多方法验证研究
Xue Wang1, Jianbo Wang1, Hua Hua1
1Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Translational Chinese Medicine Key Laboratory of Sichuan Province, Chengdu 610000, China.
Current issues in molecular biology
|September 29, 2025
概括
来自Gardenia jasminoides的Geniposide通过诱导亡和调节关键癌症途径来抑制口腔状细胞癌 (OSCC). 这种天然化合物在OSCC治疗中表现有前途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 自然产品 化学 化学
背景情况:
- 加德尼亚 jasminoides J.Ellis是一个有价值的药用植物.
- 基尼化物是来自花果的天然化物,具有抗癌性质.
- 口腔状细胞癌 (OSCC) 是一个重大的健康问题.
研究的目的:
- 调查基尼胺对OSCC的作用机制.
- 在OSCC治疗中识别基尼胺的潜在分子标.
- 评估基尼胺对OSCC的治疗潜力.
主要方法:
- 网络药理学在OSCC中确定了145个基尼胺的潜在点.
- 分子对接和动力学模拟评估了基因胺与AKT1和EGFR的结合.
- 细胞实验 (HSC-3细胞) 分析了基尼对细胞活力,细胞亡和蛋白质表达的影响.
主要成果:
- 基尼胺剂量取决于抑制HSC-3细胞活性和诱导亡.
- 网络药理学强调AKT1,EGFR,SRC,HSP90AA1和PIK3R1作为核心目标.
- 热尼化物调节PI3K-Akt信号通路和与亡相关的蛋白质 (p-EGFR,p-AKT,Bcl-2,PTEN,Bax,Caspase-3).
结论:
- 热尼胺通过诱导亡,有效地抑制OSCC的进展.
- 该机制涉及调节PI3K-Akt信号通路和关键蛋白质.
- 基尼胺显示出作为治疗口腔状细胞癌的治疗剂的潜力.
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K


